[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-352536-105":59,"doc-detail-352536-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","osbpl3-driven-sterol-metabolic-reprogramming-promotes-oncogenic-signaling-and-therapeutic-resistance-in-pancreatic-cancer-research-paper","OSBPL3-driven sterol metabolic reprogramming promotes oncogenic signaling and therapeutic resistance in pancreatic cancer - Research Paper","","OSBPL3 is a lipid-transport and metabolic-regulation member of the OSBP family, but its functional role and molecular mechanisms in pancreatic cancer remain unclear. Using single-cell and spatial transcriptomics with functional assays across disease stages, the study links OSBPL3 expression to proliferation, stemness, migration, invasion, and chemoresistance. OSBPL3-upregulated tumors show reduced oxaliplatin sensitivity, driven through oncogenic NOTCH signaling and cholesterol ester/steroid metabolic enrichment, with key cholesterol-synthesis enzymes suppressing these phenotypes in vivo. ",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/osbpl3-driven-sterol-metabolic-reprogramming-promotes-oncogenic-signaling-and-therapeutic-resistance-in-pancreatic-cancer-research-paper/352536/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/osbpl3-driven-sterol-metabolic-reprogramming-promotes-oncogenic-signaling-and-therapeutic-resistance-in-pancreatic-cancer-research-paper/352536.png","ImageObject",300,407,{"name":92,"@type":93},"Aurelia","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-05","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What role does OSBPL3 play in pancreatic cancer progression?","Question",{"text":112,"@type":113},"OSBPL3 is highly expressed across pancreatic inflammation, precursor lesions, and pancreatic ductal adenocarcinoma stages. Elevated OSBPL3 enhances proliferation, stemness, migration, invasion, and metastasis, indicating a pivotal role in initiation and progression.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How was OSBPL3 investigated in this study?",{"text":117,"@type":113},"Single-cell and spatial transcriptomic analyses were combined with functional experiments across disease stages. OSBPL3 knockdown and overexpression cell lines were used to assess proliferation, stemness, metastasis, and chemoresistance, followed by integration with single-cell transcriptomics and mass spectrometry for mechanism validation.",{"name":119,"@type":110,"acceptedAnswer":120},"Which pathway connects OSBPL3 to therapeutic resistance?",{"text":121,"@type":113},"Increased OSBPL3 reduces sensitivity to oxaliplatin, and inhibition of the NOTCH pathway attenuates the drug resistance and stemness features induced by OSBPL3 upregulation. This supports OSBPL3-mediated malignancy through oncogenic NOTCH signaling.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},352536,1790500267,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},1099514068365,"https://ap-avatar.wpscdn.com/avatar/10000253d8d9f28188e?x-image-process=image/resize,m_fixed,w_180,h_180&k=1794309523707217728","Theranostics 2026, Vol. 16, Issue 9 4745  \nIvyspring  \nInternational Publisher  \nTheranostics  \n2026; 16(9): 4745-4767. doi: 10.7150/thno.113637  \nResearch Paper  \nOSBPL3-driven sterol metabolic reprogramming promotes oncogenic signaling and therapeutic resistance in pancreatic cancer  \nQihui Sun1,3\\#, Xiaojia Li1,3\\#, Qi Zou1,2,3\\#, Yang Chen1,3, Xiaoqi Zhu1,2,3, Hailin Jiang1,3, Tingting Jiang1,3, Fang Wei1,2,3, Keping Xie1,2,3􀀍  \n1. Center for Pancreatic Cancer Research, The South China University of Technology School of Medicine, Guangzhou, Guangdong 510006, China.  \n2. Guangzhou Digestive Disease Center, Guangzhou First People’s Hospital and The Second Affiliated Hospital, South China University of Technology School of Medicine, Guangzhou, China.  \n3. The South China University of Technology Comprehensive Cancer Center, Guangzhou, Guangdong 510006, China.  \n\\# Q. Sun, X. Li and Q. Zou have contributed equally to this work and are considered co-first authors.  \n􀀍 Corresponding author: Keping Xie, Center for Pancreatic Cancer Research, South China University of Technology School of Medicine, Guangzhou 510006, China; [Email: mcxiekeping@scut.edu.cn](Email: mcxiekeping@scut.edu.cn).  \n© The author(s). This is an open access article distributed under the terms of the Creative Commons Attribution License ([https://creativecommons.org/licenses/by/4.0/](https://creativecommons.org/licenses/by/4.0/)). See [https://ivyspring.com/terms](https://ivyspring.com/terms) for full terms and conditions.  \nReceived: 2025.03.12; Accepted: 2025.12.02; Published: 2026.02.18  \nAbstract  \n\n| Background: As a member of the oxysterol-binding protein-like (OSBP) family, which is primarily involved in lipid transport and metabolic regulation, Oxysterol-binding protein-like protein 3 (OSBPL3), has garnered increasing attention due to its abnormal expression and functional roles in various cancers. However, the specific role and molecular mechanisms of OSBPL3 in pancreatic cancer (PDA) remain unclear.\u003Cbr>Methods: Single-cell and spatial transcriptomic data analyses combined with functional experiments were utilized to systematically evaluate OSBPL3 expression changes at various stages of PDA. Cell lines with decreased or increased expression of OSBPL3 were generated to analyze its role in cell proliferation, stemness, metastasis and chemoresistance. Single-cell transcriptomic and mass spectrometry data was further integrated with functional validation to explore the regulatory mechanisms through which OSBPL3 modulates PDA malignancy.\u003Cbr>Results: OSBPL3 was highly expressed throughout various stages of pancreatic inflammation, precursor lesions, and PDA in both human and mouse pancreatic tissues. Increased OSBPL3 expression significantly enhanced the proliferative capacity and stemness of PDA cells, and promoted their migration, invasion, and metastasis. Moreover, increased OSBPL3 expression impacted on the malignant behaviors of PDA, e.g., reduced PDA cell sensitivity to oxaliplatin, whereas inhibition of NOTCH pathway significantly attenuated the drug resistance and stemness features induced by increased OSBPL3 expression, suggesting that OSBPL3 modulated PDA malignancy via oncogenic pathways such as NOTCH signaling pathway. Furthermore, increased OSBPL3 expression was significantly associated with the enrichment of cholesterol esters and other steroid metabolites, as well as their related pathways. Inhibition of key enzymes involved in cholesterol synthesis resulted in a significant reduction in NOTCH pathway and stemness in PDA in vivo mouse models.\u003Cbr>Conclusions: Aberrant expression of OSBPL3 plays a pivotal role in PDA initiation and progression and serves as an independent prognostic factor for poor outcomes in PDA patients. OSBPL3 promotes PDA cell proliferation, stemness, and chemoresistance by mediating lipid metabolic reprogramming and regulating oncogenic pathways such as NOTCH. Therefore, inhibition of OSBPL3 expression or blockade of its ","cbCaikdd5cSHHf3i","https://ap.wps.com/l/cbCaikdd5cSHHf3i","pdf",14126106,23,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusions\n# Introduction\n## Overview of pancreatic ductal adenocarcinoma and prognosis\n## Cancer stem cells and therapy resistance\n## Signaling pathways (NOTCH, WNT, Hedgehog) and metabolic reprogramming\n# Keywords","[{\"question\":\"What role does OSBPL3 play in pancreatic cancer progression?\",\"answer\":\"OSBPL3 is highly expressed across pancreatic inflammation, precursor lesions, and pancreatic ductal adenocarcinoma stages. Elevated OSBPL3 enhances proliferation, stemness, migration, invasion, and metastasis, indicating a pivotal role in initiation and progression.\"},{\"question\":\"How was OSBPL3 investigated in this study?\",\"answer\":\"Single-cell and spatial transcriptomic analyses were combined with functional experiments across disease stages. OSBPL3 knockdown and overexpression cell lines were used to assess proliferation, stemness, metastasis, and chemoresistance, followed by integration with single-cell transcriptomics and mass spectrometry for mechanism validation.\"},{\"question\":\"Which pathway connects OSBPL3 to therapeutic resistance?\",\"answer\":\"Increased OSBPL3 reduces sensitivity to oxaliplatin, and inhibition of the NOTCH pathway attenuates the drug resistance and stemness features induced by OSBPL3 upregulation. This supports OSBPL3-mediated malignancy through oncogenic NOTCH signaling.\"}]","OSBPL3-driven sterol metabolic reprogramming promotes oncogenic signaling and therapeutic resistance in pancreatic cancer - Research Paper | PDF",1790100157,58,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/77c189de7a28352142ca7bf7d3c52107.webp",983,1272,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6f7600f3fd5d89bfac03727911823047.webp",982,1270,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e75aa7fe4764e11cdca8daaa385372ea.webp",981,1269,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/02a235a672c68cc18023ab1e81338640.webp",980,1268]